<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02823522</url>
  </required_header>
  <id_info>
    <org_study_id>ACPM11</org_study_id>
    <nct_id>NCT02823522</nct_id>
  </id_info>
  <brief_title>Non-Celiac Wheat Sensitivity: Permanent or Transient Condition?</brief_title>
  <official_title>Non-Celiac Wheat Sensitivity: Permanent or Transient Condition? A Follow-up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Palermo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Palermo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-Celiac Gluten Sensitivity (NCGS) has been recently included among the gluten-related
      diseases. Patients suffering from NCGS are diagnosed after carefully excluding celiac disease
      (CD), and immunoglobulin E (IgE)-mediated wheat allergy. Then, in the absence of sensitive
      and specific diagnostic biomarkers for NCGS, a monitoring of the patient during elimination
      and re-introduction of wheat by a double-blind placebo controlled (DBPC) challenge method has
      been suggested as diagnostic hallmark. Some studies seem to suggest that wheat components
      other than gluten can cause the symptoms, and therefore the term &quot;non-celiac wheat
      sensitivity&quot; (NCWS) has been proposed instead of NCGS. While it is well known that CD is a
      long-life condition and a strict adherence to the gluten-free diet must be maintained, it is
      unknown whether this is valid for NCWS. On the year 2012, the researchers published a
      retrospective study, including 276 patients with irritable bowel syndrome (IBS)-like symptoms
      who had been diagnosed with NCWS using a DBPC challenge during a ten-years period
      (2001-2011). The present prospective study aimed to evaluate: A) how many of these patients
      are still following a wheat-free diet, and B) which percentage was still suffering from NCWS,
      diagnosed by DBPC wheat challenge, in a subgroup of that cohort.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-Celiac Gluten Sensitivity (NCGS) has been recently included among the gluten-related
      diseases. Patients suffering from NCGS are diagnosed after carefully excluding celiac disease
      (CD) diagnosis by negative CD-specific serum antibodies and absence of intestinal villi
      atrophy, and excluding IgE-mediated wheat allergy, by negative serum specific IgE and/or skin
      prick test with wheat antigens. Then, in the absence of sensitive and specific diagnostic
      biomarkers for NCGS, a monitoring of the patient during elimination and re-introduction of
      wheat by a double-blind placebo controlled (DBPC) challenge method has been suggested as
      diagnostic hallmark. Obviously, this a cumbersome and time-consuming procedure which has been
      used in few studies.

      Despite an increasing percentage of the general population define themselves as
      &quot;gluten-sensitive&quot;, and by the year 2017 the market of the gluten-free products will be worth
      6.6 billion of dollars, doubts persist about many aspects of NCGS. Some studies seem to
      suggest that wheat components other than gluten can cause the symptoms, and therefore the
      term &quot;non-celiac wheat sensitivity&quot; (NCWS) has been proposed instead of NCGS. Furthermore,
      while it is well known that CD is a long-life condition and a strict adherence to the
      gluten-free diet must be maintained, it is unknown whether this is valid for NCWS.

      On the year 2012, the researchers published a retrospective study, including 276 patients
      with irritable bowel syndrome (IBS)-like symptoms who had been diagnosed with NCWS using a
      DBPC challenge during a ten-years period (2001-2011).

      The present prospective study aimed to evaluate the persistence of the NCWS condition in that
      cohort and, consequently, the researchers estimated : A) how many of these patients are still
      following a wheat-free diet, and B) which percentage was still suffering from NCWS, diagnosed
      by DBPC wheat challenge, in a subgroup of that cohort.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>How many patients were still following a gluten-free or a wheat-free diet</measure>
    <time_frame>Between July and November 2016</time_frame>
    <description>A structured questionnaire was administered to evaluate how many patients were still following a gluten-free diet (GFD) and how many a wheat-free diet.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the effect of the GFD on IBS symptoms</measure>
    <time_frame>Between July and November 2016</time_frame>
    <description>The researchers administered a modified version of the IBS Global Assessment of Improvement (IBS-GAI) score. A responder was defined as a patient whose symptoms were either 'moderately improved' or 'substantially improved' compared with the period preceding the NCWS diagnosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the severity of the IBS condition</measure>
    <time_frame>Between July and November 2016</time_frame>
    <description>The researchers administered the IBS Symptom Severity Scale (IBS-SSS), evaluating the change in total IBS-SSS score from the first evaluation (time of the NCWS diagnosis) and the follow-up evaluation (present study). A respondent was classified as a patient whose overall symptom severity on the IBS-SSS changed &gt;50 points.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-evaluation of the NCWS condition by DBPC-Wheat challenge</measure>
    <time_frame>Between July and November 2016</time_frame>
    <description>Finally, the repetition of the DBPC-wheat challenge will be proposed to the patients still on GFD. Those who will accept will be randomized to undergo the challenge. It will be performed with the same method used in the retrospective study.</description>
  </secondary_outcome>
  <enrollment type="Actual">276</enrollment>
  <condition>Non-Celiac Wheat Sensitivity</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patients recruitment</intervention_name>
    <description>Between July and November 2016, the patients included in the previous retrospective study were contacted by phone, mail and e-mail and invited to come back to the respective clinics where they had been initially diagnosed as NCWS patients: the Department of Internal Medicine of the University Hospital of Palermo and the Department of Internal Medicine of the Hospital of Sciacca (province of Agrigento).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients included in the previous retrospective study were contacted by phone, mail and
        e-mail and invited to come back to the respective clinics where they had been initially
        diagnosed as NCWS patients: the Department of Internal Medicine of the University Hospital
        of Palermo and the Department of Internal Medicine of the Hospital of Sciacca.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients previously diagnosed with NCWS by DBPC challenge.

        Exclusion Criteria:

          -  The 22 patients, included in the previous study, who tested positives for
             anti-endomysial antibodies (EmA) in the culture medium of the duodenal biopsies, even
             if the villi/crypts ratio in the duodenal mucosa was normal, were excluded from the
             present study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Carroccio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca</name>
      <address>
        <city>Sciacca</city>
        <state>Agrigento</state>
        <zip>92019</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine, University Hospital of Palermo</name>
      <address>
        <city>Palermo</city>
        <zip>90129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS, Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012 Feb 7;10:13. doi: 10.1186/1741-7015-10-13. Review.</citation>
    <PMID>22313950</PMID>
  </results_reference>
  <results_reference>
    <citation>Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, Hadjivassiliou M, Kaukinen K, Kelly CP, Leonard JN, Lundin KE, Murray JA, Sanders DS, Walker MM, Zingone F, Ciacci C. The Oslo definitions for coeliac disease and related terms. Gut. 2013 Jan;62(1):43-52. doi: 10.1136/gutjnl-2011-301346. Epub 2012 Feb 16.</citation>
    <PMID>22345659</PMID>
  </results_reference>
  <results_reference>
    <citation>Catassi C, Elli L, Bonaz B, Bouma G, Carroccio A, Castillejo G, Cellier C, Cristofori F, de Magistris L, Dolinsek J, Dieterich W, Francavilla R, Hadjivassiliou M, Holtmeier W, KÃ¶rner U, Leffler DA, Lundin KE, Mazzarella G, Mulder CJ, Pellegrini N, Rostami K, Sanders D, Skodje GI, Schuppan D, Ullrich R, Volta U, Williams M, Zevallos VF, Zopf Y, Fasano A. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts' Criteria. Nutrients. 2015 Jun 18;7(6):4966-77. doi: 10.3390/nu7064966.</citation>
    <PMID>26096570</PMID>
  </results_reference>
  <results_reference>
    <citation>Spence D. Bad medicine: food intolerance. BMJ. 2013 Jan 30;346:f529. doi: 10.1136/bmj.f529. Review.</citation>
    <PMID>23364064</PMID>
  </results_reference>
  <results_reference>
    <citation>Carroccio A, Rini G, Mansueto P. Non-celiac wheat sensitivity is a more appropriate label than non-celiac gluten sensitivity. Gastroenterology. 2014 Jan;146(1):320-1. doi: 10.1053/j.gastro.2013.08.061. Epub 2013 Nov 22.</citation>
    <PMID>24275240</PMID>
  </results_reference>
  <results_reference>
    <citation>Fasano A, Sapone A, Zevallos V, Schuppan D. Nonceliac gluten sensitivity. Gastroenterology. 2015 May;148(6):1195-204. doi: 10.1053/j.gastro.2014.12.049. Epub 2015 Jan 9. Review.</citation>
    <PMID>25583468</PMID>
  </results_reference>
  <results_reference>
    <citation>Carroccio A, Mansueto P, Iacono G, Soresi M, D'Alcamo A, Cavataio F, Brusca I, Florena AM, Ambrosiano G, Seidita A, Pirrone G, Rini GB. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol. 2012 Dec;107(12):1898-906; quiz 1907. doi: 10.1038/ajg.2012.236. Epub 2012 Jul 24.</citation>
    <PMID>22825366</PMID>
  </results_reference>
  <results_reference>
    <citation>Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997 Apr;11(2):395-402.</citation>
    <PMID>9146781</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2016</study_first_submitted>
  <study_first_submitted_qc>June 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2016</study_first_posted>
  <last_update_submitted>January 20, 2017</last_update_submitted>
  <last_update_submitted_qc>January 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Palermo</investigator_affiliation>
    <investigator_full_name>Pasquale Mansueto</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

